Journal profile · Multiple
FASEB BioAdvances
ISSN 2573-9832 · Wiley · United States
FASEB BioAdvances: CAS Zone 4 · Biology (2025 upgraded edition); impact factor 2.4 (journal website); fully open access; APC about USD 3,170; median 93 days to acceptance (93 articles, last 24 months); acceptance rate 42% (journal website); 98 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
FASEB BioAdvances is published by Wiley and is in Zone 4 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diverse Scientific and Economic Studies, Human auditory perception and evaluation and Educational Robotics and Engineering, together about 39.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
<em>FASEB BioAdvances</em> is an international open access journal with broad scope and interdisciplinary approach, publishing research in various areas of the life sciences.
From the journal's Aims & Scope
Research area (LetPub): Multiple
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance13.1%
- Human auditory perception and evaluationEngineering13.1%
- Educational Robotics and EngineeringComputer Science13.1%
- Adipose Tissue and MetabolismMedicine4.8%
- Extracellular vesicles in diseaseBiochemistry, Genetics and Molecular Biology4.2%
- Health and Medical Research ImpactsMedicine4%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology3.8%
- Bioeconomy and Sustainability DevelopmentAgricultural and Biological Sciences3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 2.4Publisher website ·
- CiteScore 2026-06
- 3.5LetPub ·
- CiteScore (publisher) 2025
- 3.5Publisher website ·
- SJR 2026-06
- 0.78LetPub ·
- SNIP 2026-06
- 0.65LetPub ·
- h-index
- 33OpenAlex ·
- i10-index
- 189OpenAlex ·
- 2-year mean citedness
- 2.04OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 76LetPub ·
- Articles per year (publisher) 2025
- 76Publisher website ·
- Downloads per year (publisher) 2025
- 165,138Publisher website ·
Articles by year OpenAlex count · 648 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 86 | 86 | 35 |
| 2025 | 98 | 98 | 203 |
| 2024 | 62 | 62 | 265 |
| 2023 | 50 | 50 | 351 |
| 2022 | 59 | 59 | 427 |
| 2021 | 109 | 109 | 1,955 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
93 daysMedian, submission to acceptance · P25–P75 60 days – 125 days
- Acceptance to online
- median 18 days (93 articles)
- Submission to online
- median 111 days
- Sample
- 93 articles with submission and acceptance dates (171 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 10 weeksLetPub ·
- Acceptance rate (publisher) 2025
- 42%Publisher website ·
- Submission to first decision 2025
- 15 daysPublisher website ·
- Submission to acceptance 2025
- 94 daysPublisher website ·
- Acceptance to publication 2025
- 21 daysPublisher website ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,170 / GBP 2,890 / EUR 3,540 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,880 / EUR 3,220 / GBP 2,630 | — | — | |
| LetPub | USD 2,500 / GBP 2,280 / EUR 2,800 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wiley
- Country or region
- United States
- Language
- English
- ISSN
- 2573-9832
- Society / sponsor
- Federation of American Societies for Experimental Biology
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about FASEB BioAdvances
What CAS zone is FASEB BioAdvances in?
In the 2025 upgraded edition of the CAS Journal Ranking, FASEB BioAdvances is in Zone 4 of Biology, and in Zone 4 of the minor category Biochemistry & Molecular Biology / Cell Biology. In the 2026 Xinrui edition it is in Zone 3 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of FASEB BioAdvances?
The journal's website gives an impact factor of 2.4 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 3.5, h-index 33.
How long does peer review take at FASEB BioAdvances?
Based on the dates recorded on 93 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 93 days (interquartile range 60–125 days); authors report an average review time of about 10 weeks; the journal's website gives an acceptance rate of 42% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index FASEB BioAdvances?
According to LetPub and DOAJ records, FASEB BioAdvances is indexed in ESCI, Scopus and DOAJ.
Is FASEB BioAdvances open access, and what is the APC?
FASEB BioAdvances is a fully open-access journal. APC about USD 3,170.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .